Now showing items 1-1 of 1
ROLE OF miRNome IN MENINGIOMA TUMOURS: IDENTIFICATION OF POTENTIAL MOLECULAR BIOMARKERS AND THERAPEUTIC TARGETS FOR HIGH-GRADE MENINGIOMA
(University of Plymouth, 2020)
Meningioma is the most common intracranial tumour, accounting for one third of all primary brain and central nervous system (CNS) tumours. According to the World Health Organization (WHO), meningiomas are classified as ...